Covidien Acquires CNS Therapeutics for $100,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4f5ba081-416d-47f5-8fae-955ebcbb6268&Preview=1
Date
9/25/2012
Company Name
CNS Therapeutics
Mailing Address
332 Minnesota Street Saint Paul, MN 55101
Company Description
CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics.
Website
http://www.gablofen.com
Transaction Type
M&A
Transaction Amount
$100,000,000
Transaction Round
Proceeds Purposes
M&A Terms
Additional financial terms of the transaction were not disclosed by the parties.